|
FAR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.98880000935287E-09 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
4.393600E-01 |
| Stage1-vs-Stage3 |
5.559800E-02 |
| Stage1-vs-Stage4 |
9.56749999999618E-05 |
| Stage2-vs-Stage3 |
6.897700E-02 |
| Stage2-vs-Stage4 |
3.809000E-04 |
| Stage3-vs-Stage4 |
2.543800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.0502000015793E-08 |
| Normal-vs-Asian |
4.07920364153824E-11 |
| Caucasian-vs-AfricanAmerican |
7.391000E-01 |
| Caucasian-vs-Asian |
4.819400E-01 |
| AfricanAmerican-vs-Asian |
8.713200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.88178419700125E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.804200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
5.021400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.208800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.267800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.655200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.102400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.908200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.363400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.493800E-02 |
| Classical-VS-Follicular |
8.481500E-02 |
| Classical-VS-Other |
5.509000E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
7.619400E-03 |
| Tall-VS-Other |
5.906400E-01 |
| Tall-VS-Normal |
4.23427959361788E-12 |
| Follicular-VS-Other |
3.145200E-01 |
| Follicular-VS-Normal |
9.60379997749783E-09 |
| Other-VS-Normal |
1.437270E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
5.44009282066327E-14 |
| N0-vs-N1 |
2.906200E-01 |
|
|
